Cargando…

Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism

Although high-fat diet (HFD) has been implicated in the development of colorectal cancer (CRC), the critical signaling molecule that mediates the cancer growth is not well-defined. Identifying the master regulator that controls CRC growth under HFD can facilitate the development of effective therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xianjing, Fatima, Sarwat, Chen, Minting, Xu, Keyang, Huang, Chunhua, Gong, Rui-Hong, Su, Tao, Wong, Hoi Leong Xavier, Bian, Zhaoxiang, Kwan, Hiu Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360949/
https://www.ncbi.nlm.nih.gov/pubmed/34385421
http://dx.doi.org/10.1038/s41419-021-04076-x
_version_ 1783737852722413568
author Hu, Xianjing
Fatima, Sarwat
Chen, Minting
Xu, Keyang
Huang, Chunhua
Gong, Rui-Hong
Su, Tao
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Kwan, Hiu Yee
author_facet Hu, Xianjing
Fatima, Sarwat
Chen, Minting
Xu, Keyang
Huang, Chunhua
Gong, Rui-Hong
Su, Tao
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Kwan, Hiu Yee
author_sort Hu, Xianjing
collection PubMed
description Although high-fat diet (HFD) has been implicated in the development of colorectal cancer (CRC), the critical signaling molecule that mediates the cancer growth is not well-defined. Identifying the master regulator that controls CRC growth under HFD can facilitate the development of effective therapeutics for the cancer treatment. In this study, the global lipidomics and RNA sequencing data show that, in the tumor tissues of CRC-bearing mouse models, HFD not only increases tumor weight, but also the palmitic acid level and TLR4 expression, which are reduced when HFD is replaced by control diet. These concomitant changes suggest the roles of palmitic acid and TLR4 in CRC growth. Subsequent studies show that palmitic acid regulates TLR4 expression in PU.1-dependent manner. Knockdown of PU.1 or mutations of PU.1-binding site on TLR4 promoter abolish the palmitic acid-increased TLR4 expression. The role of palmitic acid/PU.1/TLR4 axis in CRC growth is further examined in cell model and animal models that are fed either HFD or palmitic acid-rich diet. More importantly, iTRAQ proteomics data show that knockdown of TLR4 changes the metabolic enzyme profiles in the tumor tissues, which completely abolish the HFD-enhanced ATP production and cancer growth. Our data clearly demonstrate that TLR4 is a master regulator for CRC growth under HFD by programming cancer metabolism.
format Online
Article
Text
id pubmed-8360949
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83609492021-08-19 Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism Hu, Xianjing Fatima, Sarwat Chen, Minting Xu, Keyang Huang, Chunhua Gong, Rui-Hong Su, Tao Wong, Hoi Leong Xavier Bian, Zhaoxiang Kwan, Hiu Yee Cell Death Dis Article Although high-fat diet (HFD) has been implicated in the development of colorectal cancer (CRC), the critical signaling molecule that mediates the cancer growth is not well-defined. Identifying the master regulator that controls CRC growth under HFD can facilitate the development of effective therapeutics for the cancer treatment. In this study, the global lipidomics and RNA sequencing data show that, in the tumor tissues of CRC-bearing mouse models, HFD not only increases tumor weight, but also the palmitic acid level and TLR4 expression, which are reduced when HFD is replaced by control diet. These concomitant changes suggest the roles of palmitic acid and TLR4 in CRC growth. Subsequent studies show that palmitic acid regulates TLR4 expression in PU.1-dependent manner. Knockdown of PU.1 or mutations of PU.1-binding site on TLR4 promoter abolish the palmitic acid-increased TLR4 expression. The role of palmitic acid/PU.1/TLR4 axis in CRC growth is further examined in cell model and animal models that are fed either HFD or palmitic acid-rich diet. More importantly, iTRAQ proteomics data show that knockdown of TLR4 changes the metabolic enzyme profiles in the tumor tissues, which completely abolish the HFD-enhanced ATP production and cancer growth. Our data clearly demonstrate that TLR4 is a master regulator for CRC growth under HFD by programming cancer metabolism. Nature Publishing Group UK 2021-08-12 /pmc/articles/PMC8360949/ /pubmed/34385421 http://dx.doi.org/10.1038/s41419-021-04076-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hu, Xianjing
Fatima, Sarwat
Chen, Minting
Xu, Keyang
Huang, Chunhua
Gong, Rui-Hong
Su, Tao
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Kwan, Hiu Yee
Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title_full Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title_fullStr Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title_full_unstemmed Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title_short Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
title_sort toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360949/
https://www.ncbi.nlm.nih.gov/pubmed/34385421
http://dx.doi.org/10.1038/s41419-021-04076-x
work_keys_str_mv AT huxianjing tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT fatimasarwat tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT chenminting tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT xukeyang tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT huangchunhua tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT gongruihong tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT sutao tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT wonghoileongxavier tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT bianzhaoxiang tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism
AT kwanhiuyee tolllikereceptor4isamasterregulatorforcolorectalcancergrowthunderhighfatdietbyprogrammingcancermetabolism